This study was undertaken to characterize bile acid metabolism in hereditary forms of hypertriglyceridemia. Ten hypertriglyceridemic patients (type IV phenotype) with familial combined hyperlipidemia and 7 patients with monogenic familial hypertriglyceridemia (FHTG) were compared with 18 healthy controls; all subjects were males. Pool size, synthesis rate, and fractional catabolic rate of cholic and chenodeoxycholic acids were determined with an isotope dilution technique. Patients with FHTG had synthesis rates of cholic acid, chenodeoxycholic acid, and total bile acids above those seen in normal controls (P < 0.001); also the fractional catabolic rates of both bile acids were increased (P < 0.001). In contrast, bile acid kinetic parameters were-with one exception-within normal limits in patients with familial combined hyperlipidemia. The abnormality of bile acid metabolism could also be identified in a normolipidemic individual presumed to carry the gene for FHTG. The postprandial rise of serum bile acids was blunted in FHTG, indicating that the intestinal uptake of bile acids may be deficient in this condition. We conclude that FHTG, but not familial combined hyperlipidemia, is frequently associated with a defective regulation of bile acid synthesis, resulting in an abnormally high production rate of bile acids. It is hypothesized that this abnormality is important for the subsequent development of hypertriglyceridemia.
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Two common inherited disorders of lipoprotein metabolism that are associated with increased levels of very low density lipoproteins (VLDL) have been described (1) . One is familial combined hyperlipidemia (FCHL), characterized by the presence of multiple lipoprotein phenotypes (IIa, Ilb, and IV) among the relatives of a family (2) (3) (4) and in a single individual studied on different occasions (5) . The other is familial hypertriglyceridemia (FHTG) , in which hypertriglyceridemia (phenotype IV) is found in all affected family members (1, 2) .
Although FCHL and FHTG may be difficult to separate in some cases, numerous studies indicate that they are different metabolic entities. VLDL apolipoprotein (apo) B synthesis rates appears to be distinctly elevated in hypertriglyceridemic subjects (phenotype Ilb or IV) with FCHL (6) (7) (8) . Patients with FHTG, on the other hand, have normal (7, 8) or mildly elevated (6) VLDL apo-B synthesis rates that are lower than those seen in FCHL (6, 7) . In contrast, plasma VLDL triglyceride synthesis rates are higher in patients with FHTG than in those with FCHL (6, 8) . It is therefore assumed that the hypertriglyceridemia of FCHL is primarily due to overproduction of VLDL apo-B, whereas that seen in FHTG seems to be primarily due to overproduction of VLDL triglycerides (6) . Furthermore, individuals with FCHL and FHTG appear to differ in apparent risk for developing coronary artery disease (9) and in the relationship between triglyceride levels and insulin and obesity (10, 11) .
A common but not universal finding in patients with hypertriglyceridemia is overproduction of bile acids and cholesterol (for review, see ref. 12 ). Individuals with a high synthesis rate of bile acids also display an increased rate of VLDL triglyceride synthesis (13) . Whether the enhanced bile acid production in some patients with type IV pattern is a primary or a secondary phenomenon cannot be decided presently. However, several lines of evidence indicate that the metabolism of VLDL triglycerides is influenced by disturbances of bile acid metabolism (12) . Thus, induction of bile acid biosynthesis with cholestyramine treatment or biliary drainage is often linked to an increase in plasma triglyceride production rate (14, 15) . On the other hand, suppression of bile acid biosynthesis by feeding with chenodeoxycholic acid (CDCA; 3a,7a-dihydroxy-5f3-cholanic acid) is linked to a reduced synthesis of plasma VLDL triglyceride (14, 16) .
The heterogeneity of patients with type IV phenotype in regard to bile acid synthesis rate led us to ask the questions: ( 
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Normolipidemic nonobese male subjects (age range, 23-66 yr, n = 18) were studied at both centers. In addition, we studied two consistently normolipidemic brothers of patients with FHTG. One of the patients was treated with furosemide; otherwise, none of the subjects studied had been treated with drugs or diets known to affect lipid metabolism. Cholecystograms and/or examinations with ultrasound had not shown gallstones or cholecystopathy in any of the individuals studied. The protocol was approved by the Committees on Human Research of the Karolinska Institute and the University of Washington, Seattle; informed consent was obtained from each subject.
Experimental Procedure. The subjects were hospitalized in a metabolic ward during the study and given a standardized diet of natural type for 4-7 days before and during the investigation period (cf. ref. 13 ). Constant body weight was maintained, and the intake of cholesterol was about 200 mg/day in each subject. Five microcuries (1 Ci = 37 GBq) each of [24-14C] cholic acid (CA; 3a,7a,12a-trihydroxy-5f3-cholanic acid) and [24-14C] CDCA (New England Nuclear) as sodium salts dissolved in water were taken orally by the subjects in the morning before breakfast. Four to five samples of duodenal bile were collected after a 12-to 14-hr overnight fast at intervals of 1 to 3 days. Cholecystokinin octapeptide (Kinevac, Squibb) was administered i.v., and =5 ml of concentrated duodenal bile was obtained through a thin polyvinyl tube. A portion of the bile was immediately extracted for biliary lipid determination (see below). Venous blood samples were drawn several times during the period of study and analyzed for cholesterol, triglyceride, and lipoprotein pattern. Serum bile acid concentration in response to a standardized meal was determined as described (17) .
Methods. Serum cholesterol and triglycerides were measured with a Technicon AutoAnalyzer (Technicon). Lipoprotein phenotyping was done according to World Health Organization (18) as described (13) .
Measurements of Bile Acid Kinetics. After hydrolysis of the duodenal bile samples, the deconjugated bile acids were extracted and separated by thin-layer chromatography. The specific radioactivity was determined using gas/liquid chromatography and liquid scintillation counting. On the basis of the specific radioactivity curve from 4 or 5 time points, the fractional turnover rate, pool size, and synthesis of CA and CDCA were determined as outlined by Lindstedt (19) . Further details of the method have been given (13) .
Determination of Biliary Lipid Composition. The concentrations of bile acids, cholesterol, and phospholipids in duodenal bile were determined as described (20 (Table 2 ). Patients with FCHL had synthesis rates and fractional catabolic rates (FCR) of CA and CDCA that were similar to those seen in normal subjects. One subject with FCHL treated with furosemide, which elevated plasma triglyceride levels, had enhanced bile acid synthesis rates. In contrast, individuals with FHTG all displayed a clearly increased rate of bile acid synthesis (P < 0.001), particularly of CA (P < 0.001), but also of CDCA (P < 0.001). In addition, FHTG patients had an increased fractional catabolic rate (FCR) of both bile acids (P < 0.001). Note particularly the difference between two brothers that were studied, JH and GH. For several years before the study, JH had displayed hypertriglyceridemia intermittently, whereas GH had always been normolipidemic. As FHTG is usually expressed between ages 20-30 (1, 2), this implies that JH, but probably not GH, carried the gene for FHTG. During this study both brothers were normotriglyceridemic, but JH had about twice his brother's production rate of bile acids (Table 2) .
Because bile acid production decreases with increasing age (20) , we analyzed our data according to age distribution of the patients. Fig. 1 shows that FHTG was associated with a clearly increased bile acid production rate, regardless of age. Furthermore, for a given pool size of CA, FHTG exhibited an increased FCR (Fig. 2) ; similar data were obtained for CDCA (data not shown).
The consistently high production rate, as well as the increased FCR, suggested that a major abnormality of the regulation of bile acid metabolism is present in FHTG. Because bile acid production rate is regulated by the amount of bile acids returning to the liver in the portal vein (22), we estimated the fasting and postprandial inflow of bile acids in three FHTG subjects. This was achieved by determining the serum bile acid concentrations, which are known to reflect the concomitant portal venous concentrations (23) . Fig. 3 shows that the fasting concentrations of bile acids were normal in the three patients with FHTG, whereas the response in serum bile acids to a standardized meal was lower than that seen in controls. Also the areas under the curves were lower in FHTG (P < 0.05). The pattern observed in this preliminary study was relatively similar to that seen in healthy subjects during cholestyramine feeding (17), a treatment that is associated with decreased bile acid return, increased bile acid loss, and compensatory increase in bile acid synthesis (12) . These findings would thus indicate inefficient intestinal uptake of bile acids in FHTG.
Deficient bile acid return to the liver in FHTG might also result in secretion of bile supersaturated with cholesterol (24) . The biliary lipid composition (in molar 9'-cholesterol, 5 demonstrated that type IV patients with high rates of bile acid synthesis also had an elevated VLDL triglyceride production (13); this subgroup probably represents FHTG, as this disorder is generally linked to VLDL triglyceride overproduction (6) . In agreement with our results, Beil et al. (26) did not find consistent bile acid overproduction when hypertriglyceridemia was due to assumed FCHL.
The high production rate of bile acids seen in hypertriglyceridemic individuals with FHTG was also seen in an individual presumably carrying the gene, but not expressing hypertriglyceridemia at the time of study. This would imply that (i) bile acid overproduction may be a marker for the FHTG gene, and (it) the defect in bile acid metabolism is more closely related to the basic molecular defect in these patients than the hypertriglyceridemia. Obviously, more detailed studies of patients with FHTG are needed to support these hypotheses. Considering the complexity of triglyceride metabolism, it is also probable that FHTG is a heterogenous disorder, with various metabolic abnormalities in different families. Some possible pathogenetic mechanisms can now be discussed, however.
The probable explanation for the finding of increased FCR and enhanced production rate of bile acids in FHTG with normal-to-enlarged pool size is a deficient intestinal handling of bile acids. Uptake of bile acids secreted into the intestine occurs by at least two different mechanisms-passive, nonionic diffusion along the entire intestine, and active, probably carrier-mediated, uptake predominantly in the distal ileum (27) . As judged from the postprandial response in serum bile acid concentrations, FHTG patients have a normal passive uptake of bile acids [resulting in the early (30-min) rise], whereas the active uptake [contributing to the late (90-min) peak] appears deficient. That this is the consequence of reduced function of the carrier-mediated bile acid uptake in these individuals is a tempting speculation. More detailed knowledge of the normal process of active (receptor-mediated?) absorption of bile acids in humans is needed before this hypothesis can be tested. However, at least three pieces of evidence from previous studies support the concept of deficient intestinal uptake of bile acids in some subjects with hypertriglyceridemia. (i) Fasting serum concentration of CA is frequently lower than would be predicted from the pool size in type IV hyperlipoproteinemia (28) . (ii) Patients with this lipoprotein pattern tend to retain orally given CA within the bile acid pool to a lesser extent than normals (29) . (iii) Treatment of type IV patients with cholestyramine does not stimulate bile acid production further, indicating that feedback inhibition is already absent in the basal situation (30) .
Interruption of the enterohepatic circulation of bile acids results in an increased production rate of VLDL triglycerides (14, 15, 31 (14) . An attractive hypothesis states that deficient intestinal reabsorption of bile acids is a primary event in FHTG, which results in enhanced synthesis rate of bile acids and increased production of VLDL triglycerides. Factors-such as body weight, age, sex, and diet, etc.-that might further influence triglyceride synthesis or influence the rate of elimination of this load of endogenous plasma triglycerides, would then finally determine the degree of hypertriglyceridemia.
In conclusion, our study gives evidence that FHTG, but not FCHL, is characterized by a bile acid metabolic defect, resulting in an increased rate of bile acid synthesis; this may lead to the subsequent development of hypertriglyceridemia. Although discussion of mechanism remains speculative, testable hypotheses may now be formulated regarding a specific defect in this group of FHTG patients.
